|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Maryland Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MarylandLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Teva Pharmaceutical Industries Ltd.
| | | Phone: | (240) 821-9000 | Fax: | (240) 821-9001 | Year Established: | 2006 | Ticker: | TEVA | Exchange: | NYSE | Main Contact: | Kåre Schultz, President & CEO | | Other Contacts: | Sven Dethlefs, Executive VP, Global Marketing & Portfolio Hafrun Fridriksdottir, Ph.D., Executive VP, R&D Michael (Mike) McClellan, Executive VP & CFO Brendan O'Grady, Executive VP, North America Commercial David M. Stark, Executive VP & CLO Lori Queisser, Senior VP & & Global Compliance Officer
| | Company Description | Teva North America is a subsidiary of Teva Pharmaceuticals Ltd. In North America, Teva has locations in 13 states, District of Columbia, Canada and Puerto Rico and more than 9,000 employees. In fact, one in every seven prescriptions dispensed in the U.S. is a Teva product.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is a leading global pharmaceutical company, committed to providing consumers with access to high-quality healthcare by developing, producing and marketing affordable generic, innovative and specialty products, as well as active pharmaceutical ingredients.
The Company is the largest maker of generic pharmaceutical products, has a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. The branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. | |
|
|
|
|
|